May 10, 2017
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $9.95 to $7.65.
The split itself did not change the total investment value.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A (SZSE:300039) operates in the Pharmaceuticals: other industry.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A company overviewShanghai Kaibao Pharmaceutical Co., Ltd. Class A's most recent stock split was on May 10, 2017. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A (SZSE:300039) has split its stock 6 times: a 8-for-5 split on April 26, 2010, a 3-for-2 split on April 29, 2011, a 2-for-1 split on April 2, 2013, a 6-for-5 split on April 2, 2014, a 13-for-10 split on April 30, 2015, and a 13-for-10 split on May 10, 2017.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A has split its stock 6 times. This history records 6 forward splits between April 26, 2010 and May 10, 2017.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shanghai Kaibao Pharmaceutical Co., Ltd. Class A's 13-for-10 split on May 10, 2017, every 10 shares became 13 shares.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 10, 2017, 9 years ago. Companies announce splits in advance, and any new SZSE:300039 split will appear on this page.
Already premium?